Logo for LAVA Therapeutics N.V.

LAVA Therapeutics Investor Relations Material

Latest events

Logo for LAVA Therapeutics

Q1 2025

13 May, 2025
Logo for LAVA Therapeutics

Q4 2024

28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from LAVA Therapeutics N.V.

Access all reports
LAVA Therapeutics N.V. is a biotechnology company focused on developing bispecific gamma-delta T cell engagers (TCEs) for cancer treatment. The company’s proprietary Gammabody platform is designed to activate the immune system by targeting gamma-delta T cells to recognize and destroy tumor cells. LAVA Therapeutics is advancing a pipeline of investigational therapies for hematologic and solid tumors through clinical research and industry collaborations. The company is headquartered in Utrecht, Netherlands, and its shares are listed on the NASDAQ.